“At the 2018 EuroPCR Annual Meeting in Paris, Medtronic plc announced first-ever-data from the SPYRAL HTN-ON MED Study.”
“Pie Medical Imaging announced that clinical data on its CAAS vFFR (Cardiovascular Angiographic Analysis Systems for vessel Fractional Flow Reserve) software will be presented during EuroPCR 2018, May 22-25 in Paris, France.”
“Medtronic and the U.S. Food and Drug Administration (FDA) announced a Class I Urgent Medical Device Recall of the MindFrame Capture LP revascularization device on account of a risk of the delivery wire breaking or separating during use.”
“Electrophysiology is one of the most rapidly-growing areas of healthcare. That may be why it’s the focus of so many industry events including the Heart Rhythm Society’s annual conference.”
“A recent study published in Heart and Vessels has found that the use of the Baylis Medical NRG radiofrequency (RF) Transseptal Needle for transseptal punctures was linked to a 40 percent lower incidence of silent acute cerebral embolism in atrial fibrillation (AF) ablation procedure patients. “
“Cardiology medical device reprocessing company Innovative Health recently received U.S. Food and Drug Administration (FDA) clearance to reprocess the Abbott ViewFlex Xtra Diagnostic Ultrasound Catheter.”
“In a new study, cardiac contractility modulation (CCM) therapy was confirmed to significantly improve exercise tolerance (ET) and quality of life (QoL) for patients with persistent symptomatic heart failure and an ejection fraction between 25 and 45 percent.”
“Data on the effectiveness of cardiac resynchronization therapy (CRT) in patients with non-left bundle branch block (non-LBBB) is limited and when available has been shown to be suboptimal compared to LBBB patients.”
“Israel-based V-Wave Ltd. recently closed a $70 million Series C financing for its proprietary, minimally invasive implanted interatrial shunt device for treating patients with severe symptomatic heart failure (HF).”
“A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used for patients with multivessel disease (MVD) and acute myocardial infarction (AMI) with cardiogenic shock (CS).”
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!